Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Cash Flow Quality Index
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Quality Index of -0.14x as of June 2026. Operating cash flow of $-244.61K is below net income of $1.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Drugs Made In America Acquisition Corp. (DMAA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Drugs Made In America Acquisition Corp. Ordinary Shares Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Drugs Made In America Acquisition Corp. Ordinary Shares across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Drugs Made In America Acquisition Corp. cash conversion from operations.
Annual Cash Flow Quality Index for Drugs Made In America Acquisition Corp. Ordinary Shares (2025–2025)
Year-by-year earnings quality comparison for Drugs Made In America Acquisition Corp. Ordinary Shares.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-539.19K | $3.97 Million | — |